Application and mechanism of natural products and nutrient elements in COVID-19

被引:0
|
作者
Zhou, Lin
Tan, Yulin
Shi, Lei
Bai, Weibin [1 ]
Li, Xiaoling [1 ]
机构
[1] Jinan Univ, Inst Food Safety & Nutr, Guangzhou 510632, Peoples R China
关键词
Coronavirus disease; Natural products; Nutrient elements; Micronutrients; CONVERTING ENZYME 2; IMMUNE-RESPONSE; SPIKE PROTEIN; SELENIUM; SARS-COV-2; CORONAVIRUS; ACE2; EXPRESSION; INFECTION; DISEASE;
D O I
10.1016/j.jff.2024.106561
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Coronavirus disease 2019 (COVID-19) is caused by the highly contagious virus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which has caused hundreds of thousands of deaths worldwide. Finding more effective treatments has always been the focus of everyone's attention. The study found that compared with western drugs, natural products have higher bioavailability and fewer side effects, which provides a good prospect for the development of natural product-based antiviral drugs against SARS-CoV-2. The role of nutritional interventions in disease management is receiving increasing attention. Therefore, we conducted a thorough analysis of the latest literature on the effects of natural products and nutrients on COVID-19, based on reports from both domestic and international sources, to elucidate their positive role in maintaining human health. In conclusion, this paper emphasizes the potential role of natural products and nutritional interventions in the treatment of SARS-CoV-2, and explores more efficient and safer SARS-CoV-2 response strategies.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Covid-19: natural or anthropic origin?
    Hassanin, Alexandre
    Grandcolas, Philippe
    Veron, Geraldine
    MAMMALIA, 2021, 85 (01) : 1 - 7
  • [32] Receptor-Based Pharmacophore Modeling in the Search for Natural Products for COVID-19 Mpro
    Saeed, Mohd
    Saeed, Amir
    Alam, Md Jahoor
    Alreshidi, Mousa
    MOLECULES, 2021, 26 (06):
  • [33] Neurological disorders of COVID-19: insights to applications of natural products from plants and microorganisms
    Faezeh Almasi
    Wen Dang
    Fatemeh Mohammadipanah
    Ning Li
    Archives of Pharmacal Research, 2022, 45 : 909 - 937
  • [34] Neurological disorders of COVID-19: insights to applications of natural products from plants and microorganisms
    Almasi, Faezeh
    Dang, Wen
    Mohammadipanah, Fatemeh
    Li, Ning
    ARCHIVES OF PHARMACAL RESEARCH, 2022, 45 (12) : 909 - 937
  • [35] Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part-I)
    Kamal, Mohammad Amjad
    Khan, Md. Asaduzzaman
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (41) : 5221 - 5223
  • [36] Recent Clinical Trials on Natural Products and Traditional Chinese Medicine Combating the COVID-19
    Nile, Shivraj Hariram
    Kai, Guoyin
    INDIAN JOURNAL OF MICROBIOLOGY, 2021, 61 (01) : 10 - 15
  • [37] Drug target of natural products and COVID-19: how far has science progressed?
    Raman, Kannan
    Rajagopal, Kalirajan
    Ramesh, B.
    Nallasivan, P. Kumar
    Raja, M. K. Mohan M.
    Jupudi, Srikanth
    Byran, Gowramma
    Khan, Sharuk L.
    Bin Emran, Talha
    ANNALS OF MEDICINE AND SURGERY, 2023, 85 (06): : 2731 - 2742
  • [38] Drugs and natural products for the treatment of COVID-19 during 2020, the first year of the pandemic
    Jaimes-Castelan, Elia G.
    Gonzalez-Espinosa, Claudia
    Magos-Guerrero, Gil A.
    Arrieta-Cruz, Isabel
    Jimenez-Estrada, Manuel
    Reyes-Chilpa, Ricardo
    Castillo-Arellano, Jorge I.
    BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2024, 81 (01): : 53 - 72
  • [39] Natural Products as Inhibitors of COVID-19 Main Protease - A Virtual Screening by Molecular Docking
    Omrani, Marzieh
    Bayati, Mohammad
    Mehrbod, Parvaneh
    Bardazard, Kamal Asmari
    Ebrahimi, Samad Nejad
    PHARMACEUTICAL SCIENCES, 2021, 27 : S135 - S148
  • [40] Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19
    Wijayasinghe, Yasanandana S.
    Bhansali, Pravin
    Viola, Ronald E.
    Kamal, Mohammad A.
    Poddar, Nitesh K.
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (33) : 3526 - 3550